Utilizing A Single Session Problem-Solving Intervention With Caregivers of Pediatric Patients Receiving Chronic Transfusion to Treat Sickle Cell Disease

About the study

This study seeks to utilize an innovative approach of a single session problem-solving
intervention to address psychosocial factors affecting patient outcomes within the pediatric
sickle cell population. The study will be a randomized control trial of a single session
problem-solving intervention.

This original research will investigate the feasibility and efficacy of utilizing a
single-session problem-solving intervention to address problems affecting children and
families receiving chronic blood transfusions for sickle cell disease in order to: 1)
contribute to literature related to single session problem solving interventions with the
chronic transfusion sickle cell population and 2) identify a model of sustainable care that
reduces the burden of a multiple session intervention and increases access to services.
Additionally, this research aims to provide relatively low burden and potentially highly
effective intervention into regular care for this population in order to evaluate the
feasibility of integrating a single-session problem solving intervention into routine
clinical flow, thereby addressing needs more systematically that have been identified by
families. Further, this research aims to identify potential utility of medical providers
being trained on providing the intervention, which could be part of a future study.

Study point of contact

Dennis Burchette
214-456-1292
dennis.burchette@utsouthwestern.edu

Locations

1 United States site

Age

> 7 Years

Phase

N/A

Study type

Interventional

Gender

All

Interventions

Behavioral

Compensation

Unknown

participation requirements

– English speaking

– Patient and/or caregiver of patient between the ages of 7 years to less than 19 at
time of enrollment

– Patient and/or caregiver of patient diagnosis of sickle cell disease with sickle cell
– SS genotype

– Patient and/or caregiver of patient who has received chronic blood transfusions for at
least 6 months and continuing through the duration of the study

– Caregiver and patient pair agree to both participate in the study

participation restrictions

– Patient or caregiver of patient who are temporarily on blood transfusions for a
transient complication (e.g., priapism or recurrent acute chest syndrome)

– Patient and/or caregiver of patient displaying clinically evident cognitive delay
(e.g., stroke with severe cognitive deficits, intellectual disability) that would
preclude completion of measures or participation in intervention as defined by the
medical team, researcher, or psychologist.

– Patient and/or caregiver of patient who is a ward of state

Locations

  • Dallas, Texas, United States, Children's Medical Center, 75235 [Recruiting]
Last updated 2020-12-09